Evidence map›Paper›PMID 12235122›Full record

ArticleThe Journal of cell biology2002

Sphingosine-1-phosphate phosphohydrolase in regulation of sphingolipid metabolism and apoptosis.

Hervé Le Stunff, Ismael Galve-Roperh, Courtney Peterson, Sheldon Milstien, Sarah Spiegel

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of cell biology, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 78 papers.

0numbers the graph read from it
0cells of the map it votes in
78citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

78 citing papers in PubMed, 167 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Targeting the Sphingolipid Rheostat in Gliomas.International journal of molecular sciences · 2022
    Review
  10. Article
  11. Article
  12. Article
  13. Sphingosine 1-Phosphate Metabolism and Signaling.Advances in experimental medicine and biology · 2022
    Article
  14. Article
  15. Podocyte Sphingolipid Signaling in Nephrotic Syndrome.Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology · 2021
    Review
  16. Article
  17. Review
  18. Article
  19. The implications of signaling lipids in cancer metastasis.Experimental & molecular medicine · 2018
    Review
  20. Article

18 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 5 institutions in 2 countries.

Hervé Le StunffDepartment of Biochemistry and Molecular Biophysics, Medical College of Virginia Campus, Virginia Commonwealth University, Richmond, VA 23298, USA.
Ismael Galve-Roperh
Courtney Peterson
Sheldon Milstien
Sarah Spiegel
Georgetown University · USGeorgetown University Medical Center · USNational Institute of Mental Health · USUniversidad Complutense de Madrid · ESVirginia Commonwealth University Medical Center · US

Funding

SPHINGOSINE AS A MODULATOR OF CELLULAR PROLIFERATIONR01GM043880 · NIGMS · VIRGINIA COMMONWEALTH UNIVERSITY · PI SPIEGEL, SARAH · 1990 to 2023
$3.8M
Sphingosine-1 phosphate phosphohydrolaseR37GM043880 · NIGMS · VIRGINIA COMMONWEALTH UNIVERSITY · PI SPIEGEL, SARAH · 2003 to 2012
$3.2M
NIGMS NIH HHS GM 43880NIGMS NIH HHS R01 GM043880NIGMS NIH HHS R37 GM043880
6 · The paper itself

Abstract

Sphingosine-1-phosphate (S1P) is a bioactive sphingolipid metabolite that regulates diverse biological processes by binding to a family of G protein-coupled receptors or as an intracellular second messenger. Mammalian S1P phosphatase (SPP-1), which degrades S1P to terminate its actions, was recently cloned based on homology to a lipid phosphohydrolase that regulates the levels of phosphorylated sphingoid bases in yeast. Confocal microscopy surprisingly revealed that epitope-tagged SPP-1 is intracellular and colocalized with the ER marker calnexin. Moreover, SPP-1 activity and protein appeared to be mainly enriched in the intracellular membranes with lower expression in the plasma membrane. Treatment of SPP-1 transfectants with S1P markedly increased ceramide levels, predominantly in the intracellular membranes, diminished survival, and enhanced apoptosis. Remarkably, dihydro-S1P, although a good substrate for SPP-1 in situ, did not cause significant ceramide accumulation or increase apoptosis. Ceramide accumulation induced by S1P was completely blocked by fumonisin B1, an inhibitor of ceramide synthase, but only partially reduced by myriocin, an inhibitor of serine palmitoyltransferase, the first committed step in de novo synthesis of ceramide. Furthermore, S1P, but not dihydro-S1P, stimulated incorporation of [3H]palmitate, a substrate for both serine palmitoyltransferase and ceramide synthase, into C16-ceramide. Collectively, our results suggest that SPP-1 functions in an unprecedented manner to regulate sphingolipid biosynthesis and is poised to influence cell fate.

Indexed as

ApoptosisFumonisins3T3 CellsAnimalsCalcium-Binding ProteinsCalnexinCarboxylic AcidsCell LineCells, CulturedCeramidesEndoplasmic ReticulumEnzyme InhibitorsFatty Acids, MonounsaturatedHumansMembrane ProteinsMiceCalcium-Binding ProteinsCalnexinCarboxylic AcidsCeramidesEnzyme InhibitorsFatty Acids, Monounsaturatedfumonisin B1FumonisinsMembrane ProteinsPalmitic AcidPhosphoric Monoester HydrolasesSGPP1 protein, humanSphingolipidsSphingosinesphingosine-1-phosphate phosphatasethermozymocidin

Identifiers

PMID12235122
PMCPMC2173216
OpenAlexW2136920332

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.